Skip to main content
    S

    Serina Therapeutics Inc (SER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.82
    -0.12 (-6.19%)

    Market Cap: $43.43M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(3/7)
    Avg Surprise
    -36.68%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.34
    Range$-0.37 - $-0.31
    2 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.46+26.1%
    60d ago$-0.49+30.6%
    30d ago$-0.49+30.6%
    7d ago$-0.340.0%
    Current$-0.34
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.45
    Range$-0.63 - $-0.27
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.45---
    Sep 26EST
    		-$-0.34---
    Jun 26
    Reported Aug 13
    		$-0.55$-0.35-57.14%Miss+16.7%
    Mar 26
    Reported May 14
    		$-0.53$-0.44-20.45%Miss-8.2%
    Dec 25
    Reported Mar 25
    		$-0.31$-0.50+38.00%Beat+12.9%
    Sep 25
    Reported Nov 13
    		$-0.51$-0.53+3.77%Beat-488.7%
    Jun 25
    Reported Aug 11
    		$-0.66$-0.42-57.14%Miss-228.8%
    Mar 25
    Reported May 8
    		$-0.49$-0.62+20.97%Beat+85.5%
    Dec 24
    Reported Mar 24
    		$-0.36$0.42-184.79%Miss+88.9%
    Sep 24
    Reported Nov 12
    		$0.13N/AN/ABeat+102.6%
    Jun 24
    Reported Aug 9
    		$0.51N/AN/ABeat+120.7%
    Mar 24
    Reported May 14
    		$-3.38N/AN/ABeat-11.4%
    Dec 23
    Reported Mar 22
    		$-3.20N/AN/ABeat-4475.7%
    Sep 23
    Reported Nov 14
    		$-5.01N/AN/ABeat-8242.0%
    Jun 23
    Reported Sep 28
    		$-2.47N/AN/ABeat-3433.4%
    Mar 23
    Reported Mar 31
    		$-3.04N/AN/ABeat-4238.4%
    Dec 22
    Reported Mar 29
    		$-0.07N/AN/ABeat-16.7%
    Sep 22
    Reported Dec 29
    		$-0.06N/AN/ABeat-20.0%
    Jun 22
    Reported Sep 28
    		$-0.07N/AN/ABeat+0.0%
    Mar 22
    Reported Jun 28
    		$-0.07N/AN/ABeat-40.0%
    Dec 21
    Reported Mar 29
    		$-0.06N/AN/ABeat+0.0%
    Sep 21
    Reported Dec 29
    		$-0.05N/AN/ABeat+28.6%
    Jun 21
    Reported Sep 28
    		$-0.07N/AN/ABeat+0.0%
    Mar 21
    Reported Jun 28
    		$-0.05N/AN/ABeat+37.5%
    Dec 20
    Reported Mar 30
    		$-0.06N/AN/ABeat+14.3%
    Sep 20
    Reported Nov 16
    		$-0.07N/AN/ABeat+22.2%
    Jun 20
    Reported Aug 14
    		$-0.07N/AN/ABeat+12.5%
    Mar 20
    Reported Jun 29
    		$-0.08N/AN/ABeat+11.1%
    Dec 19
    Reported Mar 30
    		$-0.07N/AN/ABeat+97.8%
    Sep 19
    Reported Nov 14
    		$-0.09N/AN/ABeat-80.0%
    Jun 19
    Reported Aug 14
    		$-0.08N/AN/ABeat-700.0%
    Mar 19
    Reported Jun 29
    		$-0.09N/AN/ABeat-
    Dec 18
    Reported Mar 30
    		$-3.13N/AN/ABeat-
    Sep 18
    Reported Oct 22
    		$-0.05$0.00N/AMiss-
    Jun 18
    Reported Jul 19
    		$-0.01$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.96EV/EBITDAN/A
    Price/FCF-1.41xFCF Yield-71.09%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-207.90%ROIC-74.46%
    Financial Health
    Debt/Equity0.16xInterest Coverage10.44x
    Current Ratio6.65xQuick Ratio6.65x
    Trading Statistics
    Beta0.16Avg Volume81.28K
    52-Week High$5.2952-Week Low$1.22

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.98
    SMA 20$2.08
    SMA 50$2.38
    SMA 200$2.13
    EMA 10$1.99
    EMA 20$2.08
    EMA 50$2.20
    EMA 200$2.51

    MACD

    Line: -0.12Signal: -0.11Hist: -0.01

    ADX

    ADX: 41.4+DI: 5.4-DI: 24.4

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$2.03

    Bollinger Bands

    Upper Band$2.34
    Lower Band$1.81
    %B Position2521%(Upper)
    Band Width0.01

    RSI (14-Day)

    Neutral
    32.0

    Momentum Oscillators

    Stoch %K9.3
    Stoch %D10.6
    Williams %R-92.3
    ROC (10d)-12.5%
    Momentum-0.26
    CCI (20d)-155.7
    MFI (14d)3.3

    Volatility Measures

    ATR (14d)$0.15(8.5%)
    StdDev (20d)0.13
    Hist Vol52.1%(High)

    Volume Flow

    VWAP$1.86
    OBV224.4M
    AD Line-17.3M
    CMF (20d)-0.691

    Volume Metrics

    Avg Vol (20d)84.1K
    Vol Ratio0.3x(Low)
    VWMA (20d)$2.03

    Pivot Points

    R3$2.11
    R2$2.06
    R1$2.00
    Pivot Point$1.95
    S1$1.89
    S2$1.84
    S3$1.78

    Advanced Oscillators

    TSI-23.12
    Ultimate Osc29.3
    KST-201.75

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$130,000$0$-14,000$14,000$51,000$5,000$3.09M$29,000
    Cost of Revenue$0$0$23,000$0$0$0N/A$0$0$0$6,000$0
    Gross Profit$0$0$-23,000$0$130,000$0$-14,000$14,000$51,000$5,000$3.09M$29,000
    Operating Expenses$6.78M$6.28M$6.21M$6.39M$5.70M$5.86M$5.54M$5.33M$3.92M$2.33M$2.85M$1.49M
    R&D$3.82M$3.20M$3.40M$3.65M$3.15M$2.95M$2.37M$2.42M$1.59M$1.11M$907,000$603,000
    SG&A$2.97M$3.08M$2.81M$2.74M$2.54M$2.91M$3.17M$2.91M$2.32M$1.22M$1.94M$889,000
    Operating Income$-6,784,000$-6,280,000$-6,207,000$-6,392,000$-5,565,000$-5,858,000$-5,549,000$-5,312,000$-3,866,000$-2,321,000$241,000$-1,463,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$203,000$189,000$198,000$6,000$9,000$0$17,000$16,000$307,000$186,000$264,000$100,000
    Income Before Tax$-6,356,000$-6,891,000$-3,318,000$-4,595,000$-6,462,000$-4,822,000$-8,330,000$1.38M$5.18M$-9,437,000$1.05M$1.75M
    Income Tax Expense$0$7,000$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,356,000$-6,898,000$-3,336,000$-4,595,000$-6,462,000$-4,822,000$-2,752,000$1.38M$5.18M$-15,015,000$1.05M$1.75M
    EBITDA$-6,058,000$-6,620,000$-3,038,000$-4,573,000$-6,437,000$-4,805,000$-8,249,000$1.46M$5.85M$-9,204,000$1.32M$1.91M
    EBIT$-6,153,000$-6,702,000$-3,120,000$-4,589,000$-6,453,000$-4,822,000$-8,313,000$1.40M$5.48M$-9,251,000$1.31M$1.85M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SER

    News

    No news available

    Company news will appear here when available

    SER Valuation and Fair Value

    P/E
    -1.0x
    P/FCF
    -1.4x
    P/B
    1.6x
    See GNG's fair value

    SER Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -74.5%
    ROE
    -207.9%
    FCF yield
    -71.1%

    SER Competitors

    CompanyTicker
    INmune Bio IncINMB
    Rapid Micro Biosystems IncRPID
    Xtant Medical Holdings IncXTNT
    Dogwood Therapeutics, Inc.DWTX
    Celularity IncCELU
    eXoZymes, Inc.EXOZ
    LAVA Therapeutics NVLVTX
    Tevogen Bio Holdings Inc.TVGN

    Sector: Healthcare

    SER Bull Case vs Bear Case

    Bull case

    • SER grew quarterly revenue 154.9% year over year.

    Bear case

    • SER beat EPS estimates in 37.5% of its last 8 reported quarters.

    SER Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -36.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.34
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 0 down

    Frequently Asked Questions About SER

    Does SER pay dividends?

    Serina Therapeutics Inc (SER) does not currently pay a regular dividend.

    What is SER's market cap?

    Serina Therapeutics Inc (SER) has a market capitalization of $43.43M with a current stock price of $1.82.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In